Biosyntia (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Industry:Biotech
Business model:B2B

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.

By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.54M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Biosyntia

Name Criteria
Denmark Antag Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 5M - 10M USD
Sweden Glionova
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 5M - 10M USD
Denmark Acesion Pharma
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark AFYX Therapeutics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sofinnova Partners
Denmark BioPhero
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Chromologics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Draupnir Bio
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Sweden EnginZyme
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sofinnova Partners
Denmark Galecto Biotech
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Hoba Therapeutics
40%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Top